Emergent BioSolutions entering ‘turnaround’ phase, new CEO says - Washington...

Published on 7 Nov 2024 on The Business Journals

Emergent BioSolutions Inc. is heading into its next chapter — or “turnaround” phase, as its CEO...

Read the rest of the article

Start tracking your investments with Statfolio

Registration has opened for the Baltimore Business Journal's first event of 2025. The event will...

The Business Journals 8 Nov 2024

Emergent BioSolutions Inc (EBS) reports a robust financial performance with a 9% revenue increase...

GuruFocus.com · via Yahoo Finance 8 Nov 2024

Tesla, Alibaba rally; MercadoLibre falls in Thursday's afternoon market cap stock movers

Investing.com 7 Nov 2024

My name is Chris, and I will be your conference operator today. At this time, I would like to...

The Motley Fool · via AOL 7 Nov 2024

Emergent BioSolutions Inc. is heading into its next chapter — or “turnaround” phase, as its CEO...

The Business Journals 7 Nov 2024

On Thursday, Emergent BioSolutions Inc. (NYSE:EBS) stock is trading higher on mixed third-quarter...

Benzinga · via Yahoo Finance 7 Nov 2024

We recently published a list of 12 Best Performing Cheap Stocks in 2024. In this article, we are ...

Insider Monkey · via Yahoo Finance 14 Oct 2024

Total Revenue: $255 million for Q2 2024.NARCAN Sales: $120 million in Q2 2024.Anthrax MCM Sales: ...

GuruFocus.com · via Yahoo Finance 7 Oct 2024

Overview of BlackRock's Recent Transaction On August 31, 2024, BlackRock Inc. (Trades, Portfolio)...

GuruFocus.com · via Yahoo Finance 20 Sep 2024

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern reco...

Benzinga 3 May 2024